Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Betahistine

A medicine for vertigo that acts on histamine receptors, registered in Europe in 1970 and prescribed for balance disorders, particularly in Ménière's disease. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?Its structure closely resembles that of histamine: unlike antihistamines, however, it does not block it, but weakly mimics its action at H1 receptors while blocking H3 receptors instead.

BetahistineGo to the active ingredient →
BetahistineActive ingredientBetahistineCat. No. P-B062-001CAS 5638-76-6

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.